Premium
Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child
Author(s) -
Olamiju Brianna,
Craiglow Brittany G.
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14159
Subject(s) - vitiligo , medicine , ultraviolet b , dermatology , tofacitinib , concomitant , ultraviolet a , surgery , immunology , rheumatoid arthritis
Segmental vitiligo often presents in childhood and tends to be more recalcitrant to therapy than generalized vitiligo. Recently, Janus kinase inhibitors have emerged as a promising treatment option, with some reports suggesting that concomitant ultraviolet light exposure may enhance therapeutic response. Here, we present a child with segmental vitiligo who responded rapidly and completely to treatment with tofacitinib cream plus phototherapy.